• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

GE buys German ultrasound vendor

Article

GE Medical Systems has acquired German ultrasound vendor KranzbuhlerMedizinische Systeme (KMS), a Solingen-based firm that has beenworking closely with the Milwaukee vendor since 1994. KMS employs93 people and had revenues of DM62 million ($40.6 million)

GE Medical Systems has acquired German ultrasound vendor KranzbuhlerMedizinische Systeme (KMS), a Solingen-based firm that has beenworking closely with the Milwaukee vendor since 1994. KMS employs93 people and had revenues of DM62 million ($40.6 million) lastyear.

KMS claims a considerable market share in Europe for color Dopplerultrasound systems, and helped GE with the launch of the Logiq500 scanner. Some 73% of KMS revenues are derived from ultrasoundsales, with the rest coming from monitors for cardiotocographicanalysis as well as patient data management systems for hospitalmaternity wards.

In other GE international news, the company formed a joint venturewith a Chinese partner for manufacturing and marketing of ultrasoundequipment in China. GE Haiying Medical Systems will be based inWuxi, Jiangsu province, and is a partnership between GEMS andthe China State Shipbuilding Corporation.

GE Haiying is the third joint venture between GEMS and a Chinesepartner. Other joint ventures include GE Hangwei Medical Systems,for the manufacture of CT scanners, and a joint venture establishedin March to manufacture x-ray equipment.

Recent Videos
Computed Tomography Study Shows Emergence of Silicosis in Engineered Stone Countertop Workers
Can an Emerging AI Software for DBT Help Reduce Disparities in Breast Cancer Screening?
Skeletal Muscle Loss and Dementia: What Emerging MRI Research Reveals
Magnetoencephalopathy Study Suggests Link Between Concussions and Slower Aperiodic Activity in Adolescent Football Players
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Can 18F-Floutufolastat Bolster Detection of PCa Recurrence in Patients with Low PSA Levels After Radical Prostatectomy?
Related Content
© 2024 MJH Life Sciences

All rights reserved.